Wound dressing
Latest Bristol-Myers squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- Supramolecular filamentous assemblies for protein purification
- Classifying documents using a domain-specific natural language processing model
- COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT
Description
FIG. 1 is a top plan view of a wound dressing, showing our new design;
FIG. 2 is an end elevation view thereof; and,
FIG. 3 is a bottom plan view thereof.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D501926
Type: Grant
Filed: Oct 7, 2003
Date of Patent: Feb 15, 2005
Assignee: Bristol-Myers squibb Company (New York, NY)
Inventors: Helen Shaw (Widnes), Patrick G. Linnane (Chester)
Primary Examiner: Ian Simmons
Attorney: John M. Kilcoyne
Application Number: 29/191,413
Type: Grant
Filed: Oct 7, 2003
Date of Patent: Feb 15, 2005
Assignee: Bristol-Myers squibb Company (New York, NY)
Inventors: Helen Shaw (Widnes), Patrick G. Linnane (Chester)
Primary Examiner: Ian Simmons
Attorney: John M. Kilcoyne
Application Number: 29/191,413
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
